221 related articles for article (PubMed ID: 23836362)
1. Increased thyroid cancer risk in acromegaly.
Dagdelen S; Cinar N; Erbas T
Pituitary; 2014 Aug; 17(4):299-306. PubMed ID: 23836362
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer is the most common cancer associated with acromegaly.
Gullu BE; Celik O; Gazioglu N; Kadioglu P
Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of differentiated thyroid carcinoma in acromegaly.
Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
[TBL] [Abstract][Full Text] [Related]
5. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
6. High incidence of thyroid cancer among patients with acromegaly.
Kaldrymidis D; Papadakis G; Tsakonas G; Kaldrymidis P; Flaskas T; Seretis A; Pantazi E; Kostoglou-Athanassiou I; Peppa M; Roussou P; Diamanti-Kandarakis E
J BUON; 2016; 21(4):989-993. PubMed ID: 27685924
[TBL] [Abstract][Full Text] [Related]
7. Disease Activity May Not Affect the Prognosis of Coexisting Thyroid Cancer in Acromegalic Patients.
Gul N; Soyluk O; Dogansen SC; Kurtulmus N; Yarman S
Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):567-572. PubMed ID: 31185505
[TBL] [Abstract][Full Text] [Related]
8. Complications of acromegaly: thyroid and colon.
Tirosh A; Shimon I
Pituitary; 2017 Feb; 20(1):70-75. PubMed ID: 27631334
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.
Xiao T; Jiao R; Yang S; Wang Y; Bai X; Zhou J; Li R; Wang L; Yang H; Yao Y; Deng K; Gong F; Pan H; Duan L; Zhu H
Endocrine; 2023 Nov; 82(2):368-378. PubMed ID: 37442901
[TBL] [Abstract][Full Text] [Related]
10. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study.
Spricido IY; Feckinghaus CM; Silva RHM; Mesa Junior CO; Boguszewski CL
Growth Horm IGF Res; 2021 Feb; 56():101378. PubMed ID: 33486451
[TBL] [Abstract][Full Text] [Related]
12. Acromegaly, growth hormone and cancer risk.
Renehan AG; Brennan BM
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):639-57. PubMed ID: 18971124
[TBL] [Abstract][Full Text] [Related]
13. Follow, consider, and catch: second primary tumors in acromegaly patients.
Oguz SH; Firlatan B; Sendur SN; Dagdelen S; Erbas T
Endocrine; 2023 Apr; 80(1):160-173. PubMed ID: 36517649
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.
Dogan S; Atmaca A; Dagdelen S; Erbas B; Erbas T
Endocrine; 2014 Feb; 45(1):114-21. PubMed ID: 23670709
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
[TBL] [Abstract][Full Text] [Related]
16. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
[TBL] [Abstract][Full Text] [Related]
18. Thyroid vascularity is increased in patients with active acromegaly.
Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
[TBL] [Abstract][Full Text] [Related]
19. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up.
Herrmann BL; Baumann H; Janssen OE; Görges R; Schmid KW; Mann K
Exp Clin Endocrinol Diabetes; 2004 May; 112(5):225-30. PubMed ID: 15146366
[TBL] [Abstract][Full Text] [Related]
20. Thyroid gland changes in patients with acromegaly.
Natchev E; Vandeva S; Kovatcheva R; Kirilov G; Kalinov K; Zacharieva S
Arch Endocrinol Metab; 2020; 64(3):269-275. PubMed ID: 32555993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
